Frankfurt/ Berlin, Germany – The Leverest Platform supported Alantra acting as debt advisor to Trill impact on the financing aspects of its partnership with TT medic., a MedTech development and manufacturing partner for high-quality polymer components operating in Austria, Switzerland and Germany.
Alantra is an international financial services firm with over 25 offices globally and amongst others provides investment banking services to mid-market companies. The transaction was managed by Alantra’s Debt Advisory Team in Frankfurt led by Maximilian Rohardt and Philipp Holst.
Trill Impact is a pioneering Impact House with around EUR 1.2 billion in assets under management across its investment strategies, Impact Private Equity, Impact Ventures and Microfinance, with a team of around 55 experienced professionals based in the Nordics, Germany, Luxembourg and USA.
TT medic is active in precision medical injection molding, specializing as a contract development and manufacturing organization (CDMO) in clean room processing of high-quality polymer components. The company covers almost the entire value chain, allowing to position itself as a fully integrated partner for MedTech OEMs. Strong engineering and R&D capabilities allows TT medic to support clients at an early stage of their product development and thus foster product innovation.
TT medic caters its products to several indications and therapeutic areas, including minimally invasive surgery, wound care, surgical sealants, drug delivery and ophthalmology. The product portfolio spans from blades and fibrin sealants to high-pressure check valves, contributing to patient safety and improved medical outcomes across critical therapeutic areas. The customer base includes global, industry-leading MedTech OEMs with whom TT medic has maintained long-term relationships.
We congratulate all involved parties for the successful transaction.
“Debt financing powered by Leverest”